GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanjivani Paranterals Ltd (BOM:531569) » Definitions » Return-on-Tangible-Asset

Sanjivani Paranterals (BOM:531569) Return-on-Tangible-Asset : 15.12% (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Sanjivani Paranterals Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sanjivani Paranterals's annualized Net Income for the quarter that ended in Dec. 2024 was ₹75.9 Mil. Sanjivani Paranterals's average total tangible assets for the quarter that ended in Dec. 2024 was ₹502.2 Mil. Therefore, Sanjivani Paranterals's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was 15.12%.

The historical rank and industry rank for Sanjivani Paranterals's Return-on-Tangible-Asset or its related term are showing as below:

BOM:531569' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -124.34   Med: -5.86   Max: 25.8
Current: 18.23

During the past 13 years, Sanjivani Paranterals's highest Return-on-Tangible-Asset was 25.80%. The lowest was -124.34%. And the median was -5.86%.

BOM:531569's Return-on-Tangible-Asset is ranked better than
94.23% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.65 vs BOM:531569: 18.23

Sanjivani Paranterals Return-on-Tangible-Asset Historical Data

The historical data trend for Sanjivani Paranterals's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanjivani Paranterals Return-on-Tangible-Asset Chart

Sanjivani Paranterals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.16 8.13 25.80 22.96 19.14

Sanjivani Paranterals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.15 11.59 15.79 18.29 15.12

Competitive Comparison of Sanjivani Paranterals's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Sanjivani Paranterals's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanjivani Paranterals's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanjivani Paranterals's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Sanjivani Paranterals's Return-on-Tangible-Asset falls into.


;
;

Sanjivani Paranterals Return-on-Tangible-Asset Calculation

Sanjivani Paranterals's annualized Return-on-Tangible-Asset for the fiscal year that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=61.651/( (210.083+434.053)/ 2 )
=61.651/322.068
=19.14 %

Sanjivani Paranterals's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=75.936/( (502.187+0)/ 1 )
=75.936/502.187
=15.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2024) net income data.


Sanjivani Paranterals  (BOM:531569) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Sanjivani Paranterals Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Sanjivani Paranterals's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanjivani Paranterals Business Description

Traded in Other Exchanges
N/A
Address
Asha Nagar Park Road, 1202, B-Wing, O2 Business Commercial Park, Mulund (West), Mumbai, MH, IND, 400080
Sanjivani Paranterals Ltd is a pharmaceutical company principally engaged in providing pharmaceutical products and services. The company's main product range includes oral solids and small-volume parenteral and sterile powder formulations. The products offered by the company are anti-biotic, anti-emetic, anti-tuberculosis, anti-diabetic, anti-malarial, anti-fungal, calcium and vitamin, multivitamin, sedative, cardiovascular, anti-gout, and others. The company also provides Liquid Injection, Dry powder Injection, Capsules, Drops, and others. The firm sells its products in India and internationally.

Sanjivani Paranterals Headlines

No Headlines